Urayasu, Japan

Hajime Kamachi

This inventor holds 29 USPTO granted patents, primarily in Antibiotic Compounds. Top assignees: Bristol-Myers Company, Bristol-Myers Squibb Compnay, Bristol-Myers Squibb. Active years: 1976-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hajime Kamachi. Retrieved from https://idiyas.com/inventor/hajime-kamachi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 185(Granted Patents)


Location History:

  • Yokohama, JA (1976)
  • Ichikawa, JA (1978)
  • Ichikawa, JP (1978 - 1980)
  • Ciba, JP (1983)
  • Higashi-Katsushiki, JP (1984)
  • Chiba, JP (1987 - 1993)
  • Urayasu, JP (1983 - 2001)

Company Filing History:


Years Active: 1976-2001

Loading Chart...
Areas of Expertise:
Pradimicin Compounds
Pradimicin Derivatives
Cephalosporins
Antibacterial Agents
Chemical Compounds
Prodrug Esters
Amino Acids
Catechol-Substituted
3-Quaternary Ammonium
Dihydro-6-Mercapto
Arylacetamido
Intermediates
29 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hajime Kamachi

Introduction

Hajime Kamachi is an esteemed inventor based in Urayasu, Japan, known for his significant contributions to the field of antifungal compounds. With a remarkable portfolio of 29 patents, he has dedicated his career to developing novel solutions to combat fungal infections.

Latest Patents

Among Kamachi's most notable inventions are his recent patents that focus on pradimicin compounds. These innovative compounds possess antifungal activity and are characterized by improved water solubility, achieved through modifications of the 4′-amino or 4′-alkylamino moieties of known pradimicin compounds. Additionally, he has developed pradimicin derivatives which include neutral sugar derivatives of pradimicins. These derivatives serve as antifungal agents and come with methods for their synthesis and preparation of intermediates.

Career Highlights

Hajime Kamachi has made substantial contributions while working for prominent companies in the pharmaceutical industry, including Bristol-Myers Company and Bristol-Myers Squibb Company. His inventive work has significantly advanced the field of antifungal treatments, showcasing his commitment to improving public health.

Collaborations

Throughout his career, Kamachi has collaborated with esteemed colleagues such as Takayuki Naito and Jun Okumura. These partnerships have fostered a creative and innovative environment, leading to the advancement of new inventions and enhancing the effectiveness of their joint research efforts.

Conclusion

Hajime Kamachi's extensive patent portfolio and impactful collaborations underscore his role as a leading inventor in the pharmaceutical industry. His work with pradimicin compounds and derivatives exemplifies the innovative spirit that drives advancements in antifungal therapy. Kamachi's ongoing contributions continue to pave the way for future discoveries and improvements in the treatment of fungal infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…